Impact of bone marrow transplantation for symptomatic sickle cell disease: An interim report

Mark C. Walters, Rainer Storb, Melinda Patience, Wendy Leisenring, Terri Taylor, Jean E. Sanders, George E. Buchanan, Zora R. Rogers, Patricia Dinndorf, Sally C. Davies, Irene A G Roberts, Rosarita Dickerhoff, Andrew M. Yeager, Hsu Lewis, Joanne Kurtzberg, Kwaku Ohene-Frempong, Nancy Bunin, Francoise Bernaudin, Wing Yen Wong, J. Paul ScottDavid Margolis, Elliott Vichinsky, Donna A. Wall, Allen S. Wayne, Charles Pegelow, Rupa Redding-Lallinger, Joseph Wiley, Martin Klemperer, William C. Mentzer, Franklin O. Smith, Keith M. Sullivan

Research output: Contribution to journalArticlepeer-review

327 Scopus citations


Fifty children who had symptomatic sickle cell disease received matched sibling marrow allografts between September 1991 and March 1999, with Kaplan- Meier probabilities of survival and event-free survival of 94% and 84%, respectively. Twenty-six patients (16 male, 10 female) had at least 2 years of follow-up after transplantation and were evaluated for late effects of transplantation and for its impact on sickle cell-related central nervous system (CNS) and pulmonary disease. Patients ranged between 3.3 and 14.0 (median, 9.4) years of age and had a median follow-up of 57.9 (range 38-95) months after transplantation. Among 22 of 26 patients who had stable donor engraftment, complications related to sickle cell disease resolved, and none experienced further episodes of pain, stroke, or acute chest syndrome. All 10 engrafted patients with a prior history of stroke had stable or improved cerebral magnetic resonance imaging results. Pulmonary function tests were stable in 22 of the 26 patients, worse in two, and not studied in two. Seven of eight patients transplanted for recurrent acute chest syndrome had stable pulmonary function. Linear growth measured by median height standard deviation score improved from -0.7 before transplantation to -0.2 after transplantation. An adverse effect of busulfan conditioning on ovarian function was demonstrated in five of seven evaluable females who are currently at least 13 years of age. None of the four males tested had elevated serum gonadotropin levels. These data confirm that allogenic bone marrow transplantation establishes normal erythropoiesis and is associated with improved growth and stable CNS imaging and pulmonary function in most patients. (C) 2000 by The American Society of Hematology.

Original languageEnglish (US)
Pages (from-to)1918-1924
Number of pages7
Issue number6
StatePublished - Mar 15 2000

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology


Dive into the research topics of 'Impact of bone marrow transplantation for symptomatic sickle cell disease: An interim report'. Together they form a unique fingerprint.

Cite this